Prevalence of ADHD in nonpsychotic adult psychiatric care (ADPSYC): A multinational cross-sectional study in Europe

BMC Psychiatry

Muhammad Arif⁴  J. Antoni Ramos-Quiroga⁶  Irene Fregenal¹  Susanne Kraemer²  Jeremie Lebrec²  Johannes Thome⁵  Walter Deberdt³ 

[1] Medical Liaison, Lilly Spain, Avenida de la Industria, 30. Alcobendas, Madrid, E-28108, Spain;Lilly Deutschland GmbH, Werner Reimers-Str. 2-4, Bad Homburg, 61352, Germany;NV Eli Lilly Benelux, Markiesstraat 1, Brussels, 1000, Belgium;Leicester (Adult) ADHD Service, Leicestershire Partnership NHS Trust, Leicester, United Kingdom;Department of Psychiatry, University of Rostock, Gehlsheimer Str. 20, Rostock, D-18147, Germany;ADHD Program, Department of Psychiatry, CIBERSAM Hospital Universitari Vall d’Hebron Universitat Autònoma de Barcelona, Pg. Vall d’Hebron, Barcelona, 119-129, Spain

关键词: Europe;    Prevalence;    Psychiatric outpatients;    Adult;    Attention-deficit/hyperactivity disorder;   

Others  :  1230263
DOI  :  10.1186/s12888-015-0624-5

 received in 2015-02-15, accepted in 2015-09-30,  发布年份 2015

【 摘 要 】

Background

Attention-deficit/hyperactivity disorder (ADHD) often persists into adulthood.

This study was designed to estimate the prevalence of ADHD in adult psychiatric outpatients in several European countries.

Method

ADHD diagnosis was made using the Diagnostic Interview for ADHD in Adults, version 2.0 (DIVA), according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) and 5th Edition (DSM-5).

Results

Of 5662 patients present/approached, 2284 (40.3 %) consented, of whom 1986 patients (87.0 %) completed the study. Based on the DIVA, and applying DSM-IV-TR or DSM-5 criteria, 15.8 % (95 % confidence interval [CI] 14.2 %-17.4 %) or 17.4 % (95 % CI 15.7 %-19.0 %) of patients were diagnosed with ADHD, respectively. The prevalence of ADHD was 15.3 % when counting as non-ADHD those patients who screened positive but did not complete the DIVA (DSM-5).

Conclusions

Estimates from this study indicate that a relevant part of the psychiatric outpatient care population suffers from ADHD.

【 授权许可】

   
2015 Deberdt et al.

【 图 表 】

Fig. 1.

Fig. 2.

【 参考文献 】

• [1]Sobanski E, Bruggemann D, Alm B, Kern S, Deschner M, Schubert T, et al.: Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2007, 257:371-377.
• [2]Sobanski E, Bruggemann D, Alm B, Kern S, Philipsen A, Schmalzried H, et al.: Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. Eur Psychiatry 2008, 23:142-149.
• [3]Able SL, Johnston JA, Adler LA, Swindle RW: Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med 2007, 37:97-107.
• [4]Biederman J, Faraone SV: The effects of attention-deficit/hyperactivity disorder on employment and household income. MedGenMed 2006, 8:12.
• [5]De Graaf R, Kessler RC, Fayyad J, Ten Have M, Alonso J, Angermeyer M, et al.: The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med 2008, 65:835-842.
• [6]Kupper T, Haavik J, Drexler H, Ramos-Quiroga JA, Wermelskirchen D, Prutz C, et al.: The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents. Int Arch Occup Environ Health 2012, 85:837-847.
• [7]Ludolph AG, Kolch M, Plener PL, Schulze UM, Sprober N, Fegert JM: Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD. Z Kinder Jugendpsychiatr Psychother 2009, 37:405-411.
• [8]Barkley RA, Fischer M, Smallish L, Fletcher K: Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 2006, 45:192-202.
• [9]Brod M, Pohlman B, Lasser R, Hodgkins P: Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study. Health Qual Life Outcomes 2012, 10:47. BioMed Central Full Text
• [10]Edvinsson D, Bingefors K, Lindstrom E, Lewander T: ADHD-related symptoms among adults in out-patient psychiatry and female prison inmates as compared with the general population. Ups J Med Sci 2010, 115:30-40.
• [11]Rosler M, Retz W, Retz-Junginger P, Hengesch G, Schneider M, Supprian T, et al.: Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci 2004, 254:365-371.
• [12]Lichtenstein P, Halldner L, Zetterqvist J, Sjolander A, Serlachius E, Fazel S, et al.: Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med 2012, 367:2006-2014.
• [13]Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, et al.: Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007, 190:402-409.
• [14]Simon V, Czobor P, Balint S, Meszaros A, Bitter I: Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009, 194:204-211.
• [15]Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al.: The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006, 163:716-723.
• [16]Almeida Montes LG, Hernandez Garcia AO, Ricardo-Garcell J: ADHD prevalence in adult outpatients with nonpsychotic psychiatric illnesses. J Atten Disord 2007, 11:150-156.
• [17]Rao P, Place M: Prevalence of ADHD in four general adult outpatient clinics in North East England. Prog Neurol Psychiatry 2011, 15:7-10.
• [18][APA] American Psychiatric Association: Diagnostic and statistical manual of mental disorders. American Psychiatric Publishing, Arlington, VA; 2000.
• [19][APA] American Psychiatric Association: Diagnostic and statistical manual of mental disorders. American Psychiatric Publishing, Arlington, VA; 2013.
• [20]Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugue M, Carpentier PJ, et al.: European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 2010, 10:67. BioMed Central Full Text
• [21]Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al.: The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005, 35:245-256.
• [22]Houston JP, Kroenke K, Faries DE, Doebbeling CC, Adler LA, Ahl J, et al.: A provisional screening instrument for four common mental disorders in adult primary care patients. Psychosomatics 2011, 52:48-55.
• [23]Kooij JJS: Diagnostic Interview for ADHD in Adults 2.0 (DIVA 2.0). Adult ADHD. Diagnostic assessment and treatment. Pearson Assessment and Information BV, Amsterdam; 2010.
• [24]Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised. U.S. Department of Health, Education, and Welfare, Bethesda, MD; 1976.
• [25]Sheehan DV: The anxiety disease. Bantam Books, New York; 1983.
• [26]Brooks R: EuroQol: the current state of play. Health Policy 1996, 37:53-72.
• [27]Willcutt EG: The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 2012, 9:490-499.
• [28]Sprafkin J, Gadow KD, Weiss MD, Schneider J, Nolan EE: Psychiatric comorbidity in ADHD symptom subtypes in clinic and community adults. J Atten Disord 2007, 11:114-124.
• [29]Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, et al.: Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 2000, 48:9-20.
• [30]Van Emmerik-van OK, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, et al.: Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 2012, 122:11-19.
• [31]Wender PH, Wolf LE, Wasserstein J: Adults with ADHD. An overview. Ann N Y Acad Sci 2001, 931:1-16.
• [32]Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV: Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics 2009, 124:71-78.
• [33]Seidman LJ, Biederman J, Weber W, Hatch M, Faraone SV: Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol Psychiatry 1998, 44:260-268.
• [34]Rotger S, Richarte V, Nogueira M, Corrales M, Bosch R, Vidal R, et al.: Functioning Assessment Short Test (FAST): validity and reliability in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 2014, 264:719-727.
• [35]van de Glind G, Konstenius M, Koeter MW, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, et al.: Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend 2014, 134:158-166.
• [36]Kooij J, Boonstra AM, Swinkels SHN, Bekker EM, De Noord I, Buitelaar JK: Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord 2008, 11:445-458.